Bergen, Norway, April 23, 2025 - Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces that it has raised NOK62 ...

Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

Researchers identified a direct connection between cancer-related inflammation and the loss of motivation characteristic of advanced cancer. In a mouse study, they describe a brain pathway that starts ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic ...

New research shows that apathy and fatigue in advanced cancer are driven not by physical decline, but by inflammation-sensing neurons that suppress motivation.

Tourmaline Bio's lead asset, Pacibekitug, targets IL-6 for inflammatory and autoimmune diseases, showing promise in ASCVD, TED, and AAA with upcoming pivotal data. Pacibekitug's subcutaneous ...

For our fourth week in our Remarkable Woman series, we are highlighting a woman who uses nature to help others heal. When most of us think of therapy, we tend to visualize a small office with a ...

By uncovering unexpected chemical reaction pathways, the study could influence future research on planetary and interstellar medium chemistry, as well as pollution control and medical applications.